More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

AXX: ACL's proposed acquisition of Healius raises concerns

Jul 20, 2023 at 12:16 AM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Jul 20, 2023 at 12:16 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/axx-acls-proposed-acquisition-of-healius-raises-concerns

Australian Clinical Labs Ltd on 6ix

Story so far

  • Response to Healius' Target's StatementMay 22, 2023
  • Bidder's Statement in Takeover Offer for HealiusMar 20, 2023
  • Investor Presentation - Takeover Offer for HealiusMar 20, 2023

Earlier from Australian Clinical Labs

  • HLS: Directors' Statement re TakeoverMay 22, 2023
  • Response to Healius' Target's StatementMay 22, 2023
  • Second Supplementary Bidder's StatementMay 22, 2023
  • HLS: Lodgement of Target's StatementMay 3, 2023
  • HLS Panel Declines to Conduct ProceedingsApr 17, 2023

Later from Australian Clinical Labs

  • Takeover bid for Healius Ltd- extension of offer periodJul 20, 2023
  • HLS: ACCC Statement of IssuesJul 20, 2023
  • Appendix 4E and FY23 financial reportsAug 21, 2023
  • FY23 investor results presentationAug 21, 2023
  • HLS: Supplementary Target's StatementSep 4, 2023
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer